PHOENIX, Ariz. — April 5, 2021 — Starting today, participating Wendy’s® restaurants will begin their annual fundraiser by selling Jr. Frosty® coupon sheets for a $1 donation, with all proceeds supporting colon cancer research at the Translational Genomics Research Institute (TGen), an affiliate of City of Hope.

From today through May 30, you can put the freeze on cancer by purchasing a Jr. Frosty coupon sheet at over 180 Wendy’s locations in 10 states, including more than 60 in Arizona, while supplies last.  Each Jr. Frosty coupon sheet contains coupons for 5 free Jr. Frosty treats.

The fundraiser was established in 2007 by Wendy’s franchisee owners, Rick Holland and John Peters who are proud supporters of TGen. To date, the promotion has raised more than $1.4 million.

“Colon cancer affects the health and lives of too many, including the patient’s entire network of friends and family,” said Rick Holland, “and that is why it is rewarding to see our generous and caring customers come together in support of this promotion. The funds they help us raise directly support advances and breakthroughs against this deadly disease.”

“Cancer research needs passionate advocates like Rick and John,” said Erin Massey, Chief Development Officer at TGen, and Vice President of Philanthropy at City of Hope. “We’re grateful to them, Wendy’s, and the entire team for supporting TGen and our efforts to improve our understanding and combat complex diseases like colon cancer toward early detection and improved treatments for patients in need.”

The Jr. Frosty is a great way to chill out and lend your support to a good cause with proceeds benefiting TGen cancer research. Find a participating Wendy’s near you:

# # #

About TGen, an affiliate of City of Hope
Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based nonprofit organization dedicated to conducting groundbreaking research with life-changing results. TGen is affiliated with City of Hope, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening diseases: This precision medicine affiliation enables both institutions to complement each other in research and patient care, with City of Hope providing a significant clinical setting to advance scientific discoveries made by TGen. TGen is focused on helping patients with neurological disorders, cancer, diabetes and infectious diseases through cutting-edge translational research (the process of rapidly moving research toward patient benefit). TGen physicians and scientists work to unravel the genetic components of both common and complex rare diseases in adults and children. Working with collaborators in the scientific and medical communities worldwide, TGen makes a substantial contribution to help our patients through efficiency and effectiveness of the translational process. For more information, visit: Follow TGen on Facebook, LinkedIn and Twitter @TGen.

Media Contact
Steve Yozwiak
Senior Science Writer
[email protected]

Media Contact

RSS Feed